Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer

Published:2010-05 Issue:2 Volume:117 Page:234-238
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Resnick Kimberly E.,Frankel Wendy L.,Morrison Carl D.,Fowler Jeffrey M.,Copeland Larry J.,Stephens Julie,Kim Kenneth H.,Cohn David E.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference18 articles.

1. Cancer Statistics;Jemal;A Cancer J. Clin.,2009

2. Improved survival with an intact DNA mismatch repair system in endometrial cancer;Cohn;Obstet. Gynecol.,2006

3. Association of tumor site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer;Elsaleh;Lancet,2000

4. Tumor microsattelite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer;Ribic;N. Eng. J. Med.,2003

5. Special section: impact of the environment on colon cancer (II), Role of DNA mismatch repair in apoptotic responses to therapeutic agents;Meyers;Environ. Mol. Mutagen.,2004

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Effect of Mismatch Repair Status in Early-Stage Endometrial Cancer Treated With Adjuvant Radiation: A Multi-institutional Analysis;International Journal of Radiation Oncology*Biology*Physics;2024-07

2. Role of MLH1 and MSH2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications;Gene;2023-12

3. The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review;Cancers;2022-08-03

4. Clinicopathologic significance of DNA mismatch repair protein status in endometrial cancer;Taiwanese Journal of Obstetrics and Gynecology;2022-05

5. Microsatellite instability and chemosensitivity in solid tumours;Therapeutic Advances in Medical Oncology;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3